Paul Knight
Stock Analyst at Keybanc
(1.88)
# 3,266
Out of 5,240 analysts
142
Total ratings
46.15%
Success rate
-2.14%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XGN Exagen | Maintains: Overweight | $15 → $10 | $3.47 | +188.18% | 8 | Mar 11, 2026 | |
| STVN Stevanato Group | Maintains: Overweight | $37 → $32 | $17.86 | +79.17% | 6 | Mar 5, 2026 | |
| TMO Thermo Fisher Scientific | Upgrades: Overweight | $750 | $446.03 | +68.15% | 7 | Dec 8, 2025 | |
| WST West Pharmaceutical Services | Maintains: Overweight | $325 → $350 | $302.40 | +15.74% | 12 | Oct 24, 2025 | |
| LFCR Lifecore Biomedical | Initiates: Sector Weight | n/a | $4.50 | - | 1 | Sep 4, 2025 | |
| ATR AptarGroup | Initiates: Overweight | $220 | $117.88 | +86.63% | 1 | Sep 4, 2025 | |
| A Agilent Technologies | Reiterates: Sector Weight | n/a | $112.74 | - | 9 | Aug 28, 2025 | |
| CYRX Cryoport | Upgrades: Overweight | $15 | $13.25 | +13.21% | 9 | Aug 6, 2025 | |
| HBIO Harvard Bioscience | Downgrades: Sector Weight | n/a | $5.57 | - | 5 | Apr 9, 2025 | |
| TECH Bio-Techne | Downgrades: Sector Weight | n/a | $44.89 | - | 9 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $460 | $334.93 | +37.34% | 5 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $1.01 | - | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $8 | $2.48 | +222.58% | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $132 → $145 | $95.01 | +52.62% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $420 | $121.21 | +246.51% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $213 → $230 | $93.93 | +144.86% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $33 | $21.17 | +55.88% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $36 | $18.15 | +98.35% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $310 | $165.99 | +86.76% | 9 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $220 | $107.03 | +105.55% | 7 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $4.37 | - | 8 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $3.91 | - | 1 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $17.03 | - | 3 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $40 | $7.87 | +408.26% | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $390 → $300 | $162.85 | +84.22% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $250 | $172.38 | +45.03% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $382 → $441 | $130.04 | +239.13% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $236 | $122.04 | +93.38% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $99 | $59.47 | +66.47% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $55 | $24.72 | +122.49% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $38.25 | - | 4 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $100.79 | - | 1 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $145.00 | - | 5 | Oct 23, 2017 |
Exagen
Mar 11, 2026
Maintains: Overweight
Price Target: $15 → $10
Current: $3.47
Upside: +188.18%
Stevanato Group
Mar 5, 2026
Maintains: Overweight
Price Target: $37 → $32
Current: $17.86
Upside: +79.17%
Thermo Fisher Scientific
Dec 8, 2025
Upgrades: Overweight
Price Target: $750
Current: $446.03
Upside: +68.15%
West Pharmaceutical Services
Oct 24, 2025
Maintains: Overweight
Price Target: $325 → $350
Current: $302.40
Upside: +15.74%
Lifecore Biomedical
Sep 4, 2025
Initiates: Sector Weight
Price Target: n/a
Current: $4.50
Upside: -
AptarGroup
Sep 4, 2025
Initiates: Overweight
Price Target: $220
Current: $117.88
Upside: +86.63%
Agilent Technologies
Aug 28, 2025
Reiterates: Sector Weight
Price Target: n/a
Current: $112.74
Upside: -
Cryoport
Aug 6, 2025
Upgrades: Overweight
Price Target: $15
Current: $13.25
Upside: +13.21%
Harvard Bioscience
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $5.57
Upside: -
Bio-Techne
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $44.89
Upside: -
Mar 31, 2025
Upgrades: Overweight
Price Target: $460
Current: $334.93
Upside: +37.34%
Feb 27, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $1.01
Upside: -
Feb 12, 2025
Initiates: Overweight
Price Target: $8
Current: $2.48
Upside: +222.58%
Feb 3, 2025
Maintains: Overweight
Price Target: $132 → $145
Current: $95.01
Upside: +52.62%
Jan 23, 2025
Maintains: Overweight
Price Target: $400 → $420
Current: $121.21
Upside: +246.51%
Jan 23, 2025
Maintains: Overweight
Price Target: $213 → $230
Current: $93.93
Upside: +144.86%
Dec 13, 2024
Maintains: Overweight
Price Target: $30 → $33
Current: $21.17
Upside: +55.88%
Nov 5, 2024
Maintains: Overweight
Price Target: $28 → $36
Current: $18.15
Upside: +98.35%
Oct 23, 2024
Maintains: Overweight
Price Target: $290 → $310
Current: $165.99
Upside: +86.76%
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $107.03
Upside: +105.55%
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $4.37
Upside: -
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $3.91
Upside: -
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $17.03
Upside: -
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $7.87
Upside: +408.26%
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $162.85
Upside: +84.22%
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $172.38
Upside: +45.03%
Jan 8, 2021
Maintains: Overweight
Price Target: $382 → $441
Current: $130.04
Upside: +239.13%
Jan 8, 2021
Maintains: Overweight
Price Target: $222 → $236
Current: $122.04
Upside: +93.38%
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $59.47
Upside: +66.47%
Jan 8, 2021
Maintains: Overweight
Price Target: $47 → $55
Current: $24.72
Upside: +122.49%
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $38.25
Upside: -
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $100.79
Upside: -
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $145.00
Upside: -